LGT Capital Partners’s Autolus Therapeutics AUTL Stock Holding History

LGT Capital Partners’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-370,000	Closed	-$1.29M	–	52
2024 Q2	$1.29M	Sell	370,000 -180,000	-33%	-$777K	0.04%	56
2024 Q1	$3.51M	Hold	550,000	–	–	0.11%	55
2023 Q4	$3.54M	Hold	550,000	–	–	0.11%	58
2023 Q3	$1.28M	Hold	550,000	–	–	0.05%	62
2023 Q2	$1.31M	Hold	550,000	–	–	0.05%	63
2023 Q1	$1.01M	Hold	550,000	–	–	0.03%	63
2022 Q4	$1.04M	Hold	550,000	–	–	0.03%	60
2022 Q3	$1.18M	Hold	550,000	–	–	0.04%	65
2022 Q2	$1.56M	Buy	550,000 +50,000	+10%	+$152K	0.05%	62
2022 Q1	$2.08M	Buy	+500,000	New	+$2.1M	0.06%	65

Other funds holding AUTL

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return